CAMRY CAMPBELL: Open Payments
NPI 1891363081 · GREENVILLE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$618 in 32 payments from 10 companies in 2025. Trend: 2023 $376 · 2024 $595 · 2025 $618
Food & beverage: $573Education: $45
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $264 |
| ABBVIE INC. | 3 | $75 |
| Lilly USA, LLC | 2 | $62 |
| PFIZER INC. | 3 | $54 |
| Novo Nordisk Inc | 3 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| VivaQuant Inc, dba Rhythm Express | 1 | $25 |
| Corcept Therapeutics | 1 | $22 |
| Astellas Pharma US Inc | 1 | $17 |
| Amgen Inc. | 1 | $14 |
Products named: AIRSUPRA, LINZESS, VRAYLAR, RHYTHM EXPRESS, Korlym, PREVNAR 20, Ozempic, Saxenda.
Industry payments across MS — which companies pay providers there.
